GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Longevity Biomedical Inc (NAS:LBIO) » Definitions » EV-to-Revenue

Longevity Biomedical (Longevity Biomedical) EV-to-Revenue : (As of May. 21, 2024)


View and export this data going back to 2050. Start your Free Trial

What is Longevity Biomedical EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Longevity Biomedical's enterprise value is $0.00 Mil. Longevity Biomedical does not have enough years/quarters to calculate its Revenue for the trailing twelve months (TTM) ended in . 20. Therefore, GuruFocus does not calculate Longevity Biomedical's EV-to-Revenue at this moment.

The historical rank and industry rank for Longevity Biomedical's EV-to-Revenue or its related term are showing as below:

LBIO's EV-to-Revenue is not ranked *
in the Biotechnology industry.
Industry Median: 8.155
* Ranked among companies with meaningful EV-to-Revenue only.

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2024-05-21), Longevity Biomedical's stock price is $0.00. Longevity Biomedical does not have enough years/quarters to calculate its Revenue per Share for the trailing twelve months (TTM) ended in . 20. Therefore, GuruFocus does not calculate Longevity Biomedical's PS Ratio at this moment.

Longevity Biomedical EV-to-Revenue Historical Data

The historical data trend for Longevity Biomedical's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Longevity Biomedical EV-to-Revenue Chart

Longevity Biomedical Annual Data
Trend
EV-to-Revenue

Longevity Biomedical Semi-Annual Data
EV-to-Revenue

Competitive Comparison of Longevity Biomedical's EV-to-Revenue

For the Biotechnology subindustry, Longevity Biomedical's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Longevity Biomedical's EV-to-Revenue Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Longevity Biomedical's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Longevity Biomedical's EV-to-Revenue falls into.


Longevity Biomedical EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Longevity Biomedical's EV-to-Revenue for today is calculated as:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=0.000/
=

Longevity Biomedical  (NAS:LBIO) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Longevity Biomedical's PS Ratiofor today is calculated as:

PS Ratio=Share Price (Today)/Revenue per Share (TTM)
=0.00/
=

Longevity Biomedical EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Longevity Biomedical's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Longevity Biomedical (Longevity Biomedical) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Longevity Biomedical Inc (NAS:LBIO) » Definitions » EV-to-Revenue
Comparable Companies
Traded in Other Exchanges
N/A
Address
12100 NE 195th street, Suite 150, Bothell, WA, USA, 98011
Website
https://www.longevitybiomedical.com
Longevity Biomedical Inc is a clinical-stage biomedical company. The company is focused on the advancement of new technologies across therapeutics, monitoring, and digital health that aim to restore tissue form and function to increase health span. Longevity is acquiring a differentiated therapeutic pipeline of late-stage clinical technologies across ophthalmology, cardiovascular disease, and soft tissue reconstruction and repair.

Longevity Biomedical (Longevity Biomedical) Headlines

No Headlines